Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass. and NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with gen...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Piper Sandler ,Julie Seidel ,Kathy Vincent ,Nasdaq ,Company Masterkey ,Piper Sandler Co ,Diamond Therapeutics Inc ,Exchange Commission ,Prospectus Department ,Diamond Therapeutics ,Black Diamond ,Private Securities Litigation Reform Act ,Annual Report ,Stern Investor ,